Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.
Welltica+ on MSN
Scientists investigate whether Ozempic could influence fertility
Scientists are investigating whether popular weight-loss drugs like Ozempic could influence fertility or interfere with birth ...
Company cuts 9,000 jobs and lowers profit forecast as Wegovy sales slow. Q3 operating profit down 30% on competition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback